Raymond James upgraded UnitedHealth Group's stock to "Outperform" with a $330 price target, citing better-than-expected expense control and improved administrative efficiency. Analyst John Ransom highlighted that even small gains in efficiency could significantly boost earnings per share. The company is also streamlining its Optum Health segment by exiting underperforming operations, which should improve margins over time. Wall Street consensus remains strong with an average price target of $366.47, indicating potential upside for investors.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
